FDA Inspection
Taro Pharmaceuticals Inc.Taro Pharmaceuticals Inc. – FDA Inspection, Sep 16, 2022
Record Details
This FDA Inspection record concerns Taro Pharmaceuticals Inc., with an inspection on September 16, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Taro Pharmaceuticals Inc.
- Inspection Date
- September 16, 2022
- Product Type
- Drugs
View Company Profile
ID · 5f06f6fb-7c0a-44ca-8fd5-6aad610d4a0c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1180887
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.110(a)Written in-process control procedures
- 21 CFR 211.100(b)SOPs not followed / documented
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Taro Pharmaceuticals Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| March 27, 2026 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 20, 2024 | Not classified | Office of Inspections and Investigations | |
| May 3, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 20, 2017 | VAI | Office of Inspections and Investigations | Generic Drug Evaluation |
| July 29, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Taro Pharmaceuticals Inc.
- FDA Inspection 1312804 - 2026-03-27
- FDA Inspection 1257703 - 2024-09-20
- FDA Inspection 1088553 - 2019-05-03
- FDA Inspection 1001628 - 2017-01-20
- FDA Inspection 984831 - 2016-07-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.